Monoclonal Mouse anti‑Human ST6GAL1 / CD75 Antibody (clone 11n35, aa27‑406, WB) LS‑C184193
Monoclonal Mouse anti‑Human ST6GAL1 / CD75 Antibody (clone 11n35, aa27‑406, WB) LS‑C184193
Antibody:
ST6GAL1 / CD75 Mouse anti-Human Monoclonal (aa27-406) (11n35) Antibody
Format:
Unconjugated, Unmodified
Overview
Antibody:
ST6GAL1 / CD75 Mouse anti-Human Monoclonal (aa27-406) (11n35) Antibody
Format:
Unconjugated, Unmodified
Specifications
Description
CD75 antibody LS-C184193 is an unconjugated mouse monoclonal antibody to human CD75 (ST6GAL1) (aa27-406). Validated for WB.
Target
Human ST6GAL1 / CD75
Synonyms
ST6GAL1 | Alpha 2,6-ST 1 | Sialyltransferase 1 | SIAT1 | ST6Gal I | ST6GalI | ST6N | B-cell antigen CD75 | CD75
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG2b
Monoclonal
Conjugations
Unconjugated
Purification
Protein A/G purified
Immunogen
Recombinant corresponding to aa27-406 from human CD75 expressed in NSO cells (P15907).
Specificity
Human CD75. No cross-reactivity with recombinant human ST6GAL2, rhST6GALNAC1, or rhST6GALNAC5.
Presentation
Lyophilized from PBS, trehalose
Reconstitution
Reconstitute in sterile PBS.
Storage
Lyophilized powder may be stored at -20°C. Stable for 1 year at -20°C. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Reconstituted product is stable for 1 year at -20°C.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human, Mouse, Rat
Applications:
IHC, IHC - Paraffin, Western blot, Peptide Enzyme-Linked Immunosorbent Assay
Species:
Human
Applications:
Western blot
Species:
Human
Applications:
IHC - Paraffin, Western blot
Species:
Human, Rat
Applications:
Western blot
Species:
Human
Applications:
IHC, IHC - Paraffin, Flow Cytometry
Reactivity:
Human
Range:
0.156-10 ng/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 3/29/2024